Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia
Lia Phillips, Jovana Pavisic, Dominder Kaur, N. Valerio Dorrello, Larisa Broglie, Nobuko Hijiya
Abstract
Key Points Standard chemotherapy can still be used for new diagnosis of acute lymphoblastic leukemia in patients with SARS-CoV-2. Corticosteroid can be given safely to patients with SARS-CoV-2 presenting with acute respiratory distress syndrome and ALL.
Topics & Concepts
MedicineAcute respiratory distressLymphoblastic LeukemiaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Respiratory distressCoronavirus disease 2019 (COVID-19)Acute leukemiaRespiratory system2019-20 coronavirus outbreakIntensive care medicineChemotherapySevere acute respiratory syndromeLeukemiaImmunologyInternal medicineLungVirologyAnesthesiaInfectious disease (medical specialty)DiseaseOutbreakCOVID-19 Clinical Research StudiesCOVID-19 and healthcare impactsChildhood Cancer Survivors' Quality of Life